Emery N. Brown's most recent trade in Humacyte Inc was a trade of 80,000 Stock Options (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Humacyte Inc | Emery N. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 80,000 | 80,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Emery N. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 50,000 | 50,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Emery N. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,500 | 8,500 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Emery N. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 8,500 | 8,500 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Emery N. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 13,000 | 13,000 | - | - | Stock Options (right to buy) |